Bao-as, Kaizen Rylle B.

HRN: 26-07-33  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2024
AMPICILLIN 500MG (VIAL)
10/15/2024
10/22/2024
IV
360mg
Q6hours
PCAP-C
Waiting Final Action 
10/17/2024
CEFTRIAXONE 1G (VIAL)
10/17/2024
10/23/2024
IV
700 Mg
Stat
PCAP C
Waiting Final Action 
10/17/2024
CEFTRIAXONE 1G (VIAL)
10/17/2024
10/23/2024
IV
700 Mg
OD
PCAP C
Waiting Final Action 
10/17/2024
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
10/17/2024
10/23/2024
ORAL
2 Ml
BID
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: